{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T20:11:11Z","timestamp":1771618271344,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005145","name":"the Basic Research Program of Jiangsu","doi-asserted-by":"crossref","award":["BK20251756"],"award-info":[{"award-number":["BK20251756"]}],"id":[{"id":"10.13039\/501100005145","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Transl. Res."],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s12265-025-10738-4","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T15:17:14Z","timestamp":1770304634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correlation Between Serum GDF11 Levels and the Progression of Ischemic Mitral Regurgitation and Long-term Prognosis in Patients with ST-segment Elevation Myocardial Infarction After Percutaneous Coronary Intervention"],"prefix":"10.1007","volume":"19","author":[{"given":"Jiangping","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kewei","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baida","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9119-0705","authenticated-orcid":false,"given":"Gangjun","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"9672","key":"10738_CR1","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/s0140-6736(09)60692-9","volume":"373","author":"M Enriquez-Sarano","year":"2009","unstructured":"Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet (London, England). 2009;373(9672):1382\u201394. https:\/\/doi.org\/10.1016\/s0140-6736(09)60692-9.","journal-title":"Lancet (London, England)"},{"issue":"9","key":"10738_CR2","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/s0002-9149(00)01119-x","volume":"86","author":"MS Feinberg","year":"2000","unstructured":"Feinberg MS, Schwammenthal E, Shlizerman L, et al. Prognostic significance of mild mitral regurgitation by color Doppler echocardiography in acute myocardial infarction [J]. Am J Cardiol. 2000;86(9):903\u20137. https:\/\/doi.org\/10.1016\/s0002-9149(00)01119-x.","journal-title":"Am J Cardiol"},{"issue":"8","key":"10738_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/circimaging.116.004841","volume":"9","author":"S Nishino","year":"2016","unstructured":"Nishino S, Watanabe N, Kimura T, et al. The course of ischemic mitral regurgitation in acute myocardial infarction after primary percutaneous coronary intervention: from emergency room to long-term follow-up. Circ Cardiovasc Imaging. 2016;9(8):e004841. https:\/\/doi.org\/10.1161\/circimaging.116.004841.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"10","key":"10738_CR4","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/sctm.20-0005","volume":"9","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Zhu J, Zhang N, et al. GDF11 enhances therapeutic efficacy of mesenchymal stem cells for myocardial infarction via YME1L-mediated OPA1 processing [J]. Stem Cells Transl Med. 2020;9(10):1257\u201371. https:\/\/doi.org\/10.1002\/sctm.20-0005.","journal-title":"Stem Cells Transl Med"},{"issue":"7","key":"10738_CR5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41419-021-03954-8","volume":"12","author":"L Chen","year":"2021","unstructured":"Chen L, Luo G, Liu Y, et al. Growth differentiation factor 11 attenuates cardiac ischemia reperfusion injury via enhancing mitochondrial biogenesis and telomerase activity [J]. Cell Death Dis. 2021;12(7):665. https:\/\/doi.org\/10.1038\/s41419-021-03954-8.","journal-title":"Cell Death Dis"},{"issue":"48","key":"10738_CR6","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1093\/eurheartj\/ehv385","volume":"36","author":"KA Olson","year":"2015","unstructured":"Olson KA, Beatty AL, Heidecker B, et al. Association of growth differentiation factor 11\/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts [J]. Eur Heart J. 2015;36(48):3426\u201334. https:\/\/doi.org\/10.1093\/eurheartj\/ehv385.","journal-title":"Eur Heart J"},{"issue":"3","key":"10738_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","volume":"40","author":"K Thygesen","year":"2019","unstructured":"Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018) [J]. Eur Heart J. 2019;40(3):237\u201369. https:\/\/doi.org\/10.1093\/eurheartj\/ehy462.","journal-title":"Eur Heart J"},{"issue":"8","key":"10738_CR8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1053\/euhj.1998.1312","volume":"20","author":"PW Verheggen","year":"1999","unstructured":"Verheggen PW, De Maat MP, Cats VM, et al. Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function. Eur Heart J. 1999;20(8):567\u201374. https:\/\/doi.org\/10.1053\/euhj.1998.1312.","journal-title":"Eur Heart J"},{"issue":"8","key":"10738_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/mca.0000000000001037","volume":"32","author":"Y Liu","year":"2021","unstructured":"Liu Y, Ye T, Chen L, et al. Systemic immune-inflammation index predicts the severity of coronary stenosis in patients with coronary heart disease. Coron Artery Dis. 2021;32(8):715\u201320. https:\/\/doi.org\/10.1097\/mca.0000000000001037.","journal-title":"Coron Artery Dis"},{"issue":"5","key":"10738_CR10","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1161\/circulationaha.104.486720","volume":"112","author":"RA Levine","year":"2005","unstructured":"Levine RA, Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts [J]. Circulation. 2005;112(5):745\u201358. https:\/\/doi.org\/10.1161\/circulationaha.104.486720.","journal-title":"Circulation"},{"issue":"8","key":"10738_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1161\/circulationaha.107.749440","volume":"118","author":"M Chaput","year":"2008","unstructured":"Chaput M, Handschumacher MD, Tournoux F, et al. Mitral leaflet adaptation to ventricular remodeling: occurrence and adequacy in patients with functional mitral regurgitation [J]. Circulation. 2008;118(8):845\u201352. https:\/\/doi.org\/10.1161\/circulationaha.107.749440.","journal-title":"Circulation"},{"issue":"10","key":"10738_CR12","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.echo.2013.07.003","volume":"26","author":"JJ Silbiger","year":"2013","unstructured":"Silbiger JJ. Novel pathogenetic mechanisms and structural adaptations in ischemic mitral regurgitation. J Am Soc Echocardiogr. 2013;26(10):1107\u201317. https:\/\/doi.org\/10.1016\/j.echo.2013.07.003.","journal-title":"J Am Soc Echocardiogr"},{"issue":"3","key":"10738_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00395-019-0728-z","volume":"114","author":"HH Su","year":"2019","unstructured":"Su HH, Liao JM, Wang YH, et al. Exogenous GDF11 attenuates non-canonical TGF-\u03b2 signaling to protect the heart from acute myocardial ischemia-reperfusion injury [J]. Basic Res Cardiol. 2019;114(3):20. https:\/\/doi.org\/10.1007\/s00395-019-0728-z.","journal-title":"Basic Res Cardiol"},{"issue":"17","key":"10738_CR14","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1093\/cvr\/cvad153","volume":"119","author":"S Kraler","year":"2023","unstructured":"Kraler S, Balbi C, Vdovenko D, et al. Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humans [J]. Cardiovasc Res. 2023;119(17):2729\u201342. https:\/\/doi.org\/10.1093\/cvr\/cvad153.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10738_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jacc.2004.06.079","volume":"45","author":"KJ Grande-Allen","year":"2005","unstructured":"Grande-Allen KJ, Borowski AG, Troughton RW, et al. Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements: an extracellular matrix and echocardiographic study. J Am Coll Cardiol. 2005;45(1):54\u201361. https:\/\/doi.org\/10.1016\/j.jacc.2004.06.079.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10738_CR16","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jtcvs.2005.04.019","volume":"130","author":"KJ Grande-Allen","year":"2005","unstructured":"Grande-Allen KJ, Barber JE, Klatka KM, et al. Mitral valve stiffening in end-stage heart failure: evidence of an organic contribution to functional mitral regurgitation [J]. J Thorac Cardiovasc Surg. 2005;130(3):783\u201390. https:\/\/doi.org\/10.1016\/j.jtcvs.2005.04.019.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6 Suppl","key":"10738_CR17","doi-asserted-by":"publisher","first-page":"S198","DOI":"10.1016\/s0003-4975(98)01106-0","volume":"66","author":"KS Kunzelman","year":"1998","unstructured":"Kunzelman KS, Quick DW, Cochran RP. Altered collagen concentration in mitral valve leaflets: biochemical and finite element analysis. Ann Thorac Surg. 1998;66(6 Suppl):S198-205. https:\/\/doi.org\/10.1016\/s0003-4975(98)01106-0.","journal-title":"Ann Thorac Surg"},{"issue":"19","key":"10738_CR18","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1161\/circulationaha.107.704197","volume":"116","author":"M Bujak","year":"2007","unstructured":"Bujak M, Ren G, Kweon HJ, et al. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling [J]. Circulation. 2007;116(19):2127\u201338. https:\/\/doi.org\/10.1161\/circulationaha.107.704197.","journal-title":"Circulation"},{"issue":"10","key":"10738_CR19","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/s41419-020-03120-6","volume":"11","author":"Z Li","year":"2020","unstructured":"Li Z, Xu H, Liu X, et al. GDF11 inhibits cardiomyocyte pyroptosis and exerts cardioprotection in acute myocardial infarction mice by upregulation of transcription factor HOXA3 [J]. Cell Death Dis. 2020;11(10):917. https:\/\/doi.org\/10.1038\/s41419-020-03120-6.","journal-title":"Cell Death Dis"},{"issue":"4","key":"10738_CR20","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1007\/s12265-023-10358-w","volume":"16","author":"B Xu","year":"2023","unstructured":"Xu B, Chen K, Su W, et al. Correlation between GDF11 serum levels, severity of coronary artery lesions, and the prognosis of patients with ST-segment elevation myocardial infarction [J]. J Cardiovasc Transl Res. 2023;16(4):938\u201347. https:\/\/doi.org\/10.1007\/s12265-023-10358-w.","journal-title":"J Cardiovasc Transl Res"},{"issue":"17","key":"10738_CR21","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.jacc.2013.01.064","volume":"61","author":"J Beaudoin","year":"2013","unstructured":"Beaudoin J, Handschumacher MD, Zeng X, et al. Mitral valve enlargement in chronic aortic regurgitation as a compensatory mechanism to prevent functional mitral regurgitation in the dilated left ventricle [J]. J Am Coll Cardiol. 2013;61(17):1809\u201316. https:\/\/doi.org\/10.1016\/j.jacc.2013.01.064.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10738_CR22","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.cell.2013.04.015","volume":"153","author":"FS Loffredo","year":"2013","unstructured":"Loffredo FS, Steinhauser ML, Jay SM, et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy [J]. Cell. 2013;153(4):828\u201339. https:\/\/doi.org\/10.1016\/j.cell.2013.04.015.","journal-title":"Cell"},{"issue":"6184","key":"10738_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1126\/science.1251152","volume":"344","author":"M Sinha","year":"2014","unstructured":"Sinha M, Jang YC, Oh J, et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science (New York, NY). 2014;344(6184):649\u201352. https:\/\/doi.org\/10.1126\/science.1251152.","journal-title":"Science (New York, NY)"},{"issue":"1","key":"10738_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.cmet.2015.05.010","volume":"22","author":"MA Egerman","year":"2015","unstructured":"Egerman MA, Cadena SM, Gilbert JA, et al. GDF11 increases with age and inhibits skeletal muscle regeneration [J]. Cell Metab. 2015;22(1):164\u201374. https:\/\/doi.org\/10.1016\/j.cmet.2015.05.010.","journal-title":"Cell Metab"},{"issue":"4","key":"10738_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12631","volume":"52","author":"H Luo","year":"2019","unstructured":"Luo H, Guo Y, Liu Y, et al. Growth differentiation factor 11 inhibits adipogenic differentiation by activating TGF-beta\/Smad signalling pathway. Cell Prolif. 2019;52(4):e12631. https:\/\/doi.org\/10.1111\/cpr.12631.","journal-title":"Cell Prolif"},{"issue":"6","key":"10738_CR26","doi-asserted-by":"publisher","first-page":"G909","DOI":"10.1152\/ajpgi.00159.2018","volume":"315","author":"L Wang","year":"2018","unstructured":"Wang L, Wang Y, Wang Z, et al. Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3 inflammasome activation [J]. Am J Physiol Gastrointest Liver Physiol. 2018;315(6):G909\u201320. https:\/\/doi.org\/10.1152\/ajpgi.00159.2018.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"10738_CR27","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","volume":"43","author":"JA Ambrose","year":"2004","unstructured":"Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update [J]. J Am Coll Cardiol. 2004;43(10):1731\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2003.12.047.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10738_CR28","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/thoraxjnl-2016-209352","volume":"72","author":"K Onodera","year":"2017","unstructured":"Onodera K, Sugiura H, Yamada M, et al. Decrease in an anti-ageing factor, growth differentiation factor 11, in chronic obstructive pulmonary disease [J]. Thorax. 2017;72(10):893\u2013904. https:\/\/doi.org\/10.1136\/thoraxjnl-2016-209352.","journal-title":"Thorax"},{"key":"10738_CR29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.biopha.2018.04.091","volume":"103","author":"F Tang","year":"2018","unstructured":"Tang F, Ling C, Liu J. Reduced expression of growth differentiation factor 11 promoted the progression of chronic obstructive pulmonary disease by activating the AKT signaling pathway. Biomed Pharmacotherapy = Biomedecine & pharmacotherapie. 2018;103:691\u20138. https:\/\/doi.org\/10.1016\/j.biopha.2018.04.091.","journal-title":"Biomed Pharmacotherapy = Biomedecine & pharmacotherapie"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10738-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-025-10738-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10738-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T19:26:45Z","timestamp":1771615605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-025-10738-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10738"],"URL":"https:\/\/doi.org\/10.1007\/s12265-025-10738-4","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the No. 904 Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army (Ethics No. 20241009). Patients were informed of the Declaration of Confidentiality of Patient Information at the time of their visit and ensured that their privacy was adequately protected to maintain the confidentiality of patient information, and written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Informed Consent"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"All authors have no conflict of interest in this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"All authors disclosed no relevant relationships.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}